Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia: PRISCA Study

NCT04276012 is registered in ClinicalTrials.gov with Dr. Pere Roura-Poch as lead sponsor.

NCT NCT04276012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia: PRISCA Study
Lead sponsor
Dr. Pere Roura-Poch
Phase
Not applicable
Overall status
Unknown status
Start date
January 20, 2020
Completion date
February 28, 2021
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, schizophrenia